Article Details

Orphagen Pharmaceuticals Receives NIH Funding Award to Advance a Novel Drug for ... - BioSpace

Retrieved on: 2024-12-09 14:43:47

Tags for this article:

Click the tags to see associated articles and topics

Orphagen Pharmaceuticals Receives NIH Funding Award to Advance a Novel Drug for ... - BioSpace. View article details on hiswai:

Summary

The article outlines Orphagen Pharmaceuticals' funding for developing OR-812, an innovative treatment for IBD, potentially impacting diabetes-related autoimmune inflammatory bowel diseases. Tags denote related gastrointestinal and autoimmune topics, emphasizing drug mechanisms and company initiatives.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up